Use of ciprofloxacin in cystic fibrosis patients

The American Journal of Medicine

Volumn 87, Issue 5 SUPPL. 1, 1989, Pages

  Bosso, John A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CYSTIC FIBROSIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG FUNCTION; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS;

ADULT; CIPROFLOXACIN; CYSTIC FIBROSIS; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMAN; LUNG DISEASES; MALE; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS INFECTIONS; SUPPORT, NON-U.S. GOV'T;

EID: 0024398571     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(89)90040-5     Document Type: Article

References (35)

1. Pseudomonas aeruginosa: biology, mechanisms of virulence, epidermiology
2. Changing susceptibility of Pseudomonas aeruginosa isolates from cystic fibrosis patients with the clinical use of newer antibiotics
3. Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis
4. Imipenem/cilastatin in acute pulmonary exacerbations of cystic fibrosis
5. Clinical pharmacology of antibiotics and other drugs in cystic fibrosis
6. In vitro activity of ciprofloxacin (Bay o 9867)
7. In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinolone derivatives
8. In vitro activity of ciprofloxacin against aerobic gram-negative bacteria
9. In vitro activity of ciprofloxacin and other antibacterial agents against Pseudomonas aeruginosa and Pseudomonas cepacia from cystic fibrosis patients
10. In vitro activity of ciprofloxacin combined with azlocillin
11. Comprehensive evaluation of ciprofloxacin-aminoglycoside combinations against Enterobacteriaceae and Pseudomonas aeruginosa strains
12. Reduced virulence in ciprofloxacin-resistant variants of Pseudomonas aeruginosa strains
13. A new prognostic score and clinical evaluation system for cystic fibrosis
14. Long-term study of one hundred five patients with cystic fibrosis
15. Ceftazidime in cystic fibrosis: pharmacokinetics and therapeutic response
16. The chest roentgenogram in cystic fibrosis: a new scoring system
17. Pseudomonas
18. Antibiotic susceptibility testing by a standardized disc method
19. Efficacy of ciprofloxacin in patients with cystic fibrosis
20. Ciprofloxacin versus tobramycin plus azlocillin in pulmonary exacerbations in adult patients with cystic fibrosis
21. Ciprofloxacin in cystic fibrosis
22. Ciprofloxacin monotherapy for acute pulmonary exacerbations of cystic fibrosis
23. Randomized study of two dosing regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis
24. Ciprofloxacin therapy in cystic fibrosis
25. Ciprofloxacin comparative data in cystic fibrosis
26. Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis
27. The efficacy and safety of ciprofloxacin and ofloxacin in chronic Pseudomonas aeruginosa infection in cystic fibrosis
28. Ciprofloxacin therapy in cystic fibrosis
29. Summary of a workshop on ciprofloxacin use in patients with cystic fibrosis
30. Juvenile canine drug-induced arthropathy: clinicopathological studies on articular lesions caused by oxolonic and pipemidic acids
31. Toxicological studies on pipemidic acid V Effect on diarthrodial joints in experimental animals
32. Arthropathy in a patient with cystic fibrosis taking ciprofloxacin
33. Ciprofloxacin and allergic interstitial nephritis
34. Synergistic nephrotoxicity due to ciprofloxacin and cyclosporine